Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K

The value of second-generation gene sequencing in lung cancer immunotherapy with concurrent infections

Yaqin Zhang1,2, Qiangqiang Zhang1, Lu Wang3

  • 1Department of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, 434000, China.

BMC Cancer
|October 23, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ImmunotherapyLung cancerMetagenomic second-generation sequencingPathogen detectionPulmonary infection

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.9K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

338

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K